Concepedia

Jürgen Dinges

JD

Statistics

Publications

16

Citations

4.3K

H-Index

13

Active since

1991

Affiliations

Abbott Fund(Current)

Abbott (United States)

Abbott (United Kingdom)

AbbVie (United States)

Jürgen Dinges is an author at Abbott Fund specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1991–2016

16

Publications

16

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations

, , +14

Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x <sub>L</sub> from NMR and Parallel Synthesis

Andrew M. Petros, Jürgen Dinges, David J. Augeri et al. · Journal of Medicinal Chemistry · 2005 · 293 citations

, , +14

NMR-Based Discovery of Lead Inhibitors That Block DNA Binding of the Human Papillomavirus E2 Protein

Philip J. Hajduk, Jürgen Dinges, Gregory F. Miknis et al. · Journal of Medicinal Chemistry · 1997 · 168 citations · Full text

, , +17

Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis

Philip J. Hajduk, Jürgen Dinges, Jeffrey M. Schkeryantz et al. · Journal of Medicinal Chemistry · 1999 · 119 citations · Full text

, , +16

A convergent approach toward the tigliane ring system

William G. Dauben, Jürgen Dinges, Timothy C. Smith · The Journal of Organic Chemistry · 1993 · 99 citations

, , +5

1–5 of 16